194 related articles for article (PubMed ID: 28621225)
1. Decreased expression of MGMT in correlation with aberrant DNA methylation in esophageal cancer patients from North India.
Rehman AU; Saikia S; Iqbal MA; Ahmad I; Sadaf ; Anees A; Aravinda PS; Mishra PK; Hedau S; Saluja SS; Medhi S; Husain SA
Tumour Biol; 2017 Jun; 39(6):1010428317705770. PubMed ID: 28621225
[TBL] [Abstract][Full Text] [Related]
2. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
[TBL] [Abstract][Full Text] [Related]
3. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of MGMT gene in serum of patients with esophageal squamous cell carcinoma in North East India.
Das M; Sharma SK; Sekhon GS; Saikia BJ; Mahanta J; Phukan RK
Asian Pac J Cancer Prev; 2014; 15(22):9955-60. PubMed ID: 25520135
[TBL] [Abstract][Full Text] [Related]
5. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas.
He J; Shan Z; Li L; Liu F; Liu Z; Song M; Zhu H
Oncol Rep; 2011 Nov; 26(5):1305-13. PubMed ID: 21769436
[TBL] [Abstract][Full Text] [Related]
6. Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer.
Shilpa V; Bhagat R; Premalata CS; Pallavi VR; Ramesh G; Krishnamoorthy L
Indian J Med Res; 2014 Nov; 140(5):616-23. PubMed ID: 25579142
[TBL] [Abstract][Full Text] [Related]
7. Promoter Hypermethylation and Its Impact on Expression of MGMT Gene in the GIT Malignant Patients of Kashmiri Origin.
Bhat AA; Wani HA; Ishaq S; Waza AA; Malik RA; Shabir I; Jeelani S; Kadla S; Qureshie W; Masood A; Majid S
Cancer Invest; 2017 Feb; 35(2):116-121. PubMed ID: 28135856
[TBL] [Abstract][Full Text] [Related]
8. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India.
Nehru GA; Pai R; Samuel P; Chacko AG; Chacko G
Neurol India; 2012; 60(5):481-6. PubMed ID: 23135024
[TBL] [Abstract][Full Text] [Related]
9. MGMT promoter methylation status in Merkel cell carcinoma: in vitro versus invivo.
Improta G; Ritter C; Pettinato A; Vasta V; Schrama D; Fraggetta F; Becker JC
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1489-1497. PubMed ID: 28405827
[TBL] [Abstract][Full Text] [Related]
10. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.
Baumann S; Keller G; Pühringer F; Napieralski R; Feith M; Langer R; Höfler H; Stein HJ; Sarbia M
Int J Cancer; 2006 Jul; 119(2):264-8. PubMed ID: 16477636
[TBL] [Abstract][Full Text] [Related]
12. Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomas.
Buttarelli FR; Massimino M; Antonelli M; Lauriola L; Nozza P; Donofrio V; Arcella A; Oliva MA; Di Rocco C; Giangaspero F
Childs Nerv Syst; 2010 Aug; 26(8):1051-6. PubMed ID: 20552207
[TBL] [Abstract][Full Text] [Related]
13. MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
Yousuf A; Bhat MY; Pandith AA; Afroze D; Khan NP; Alam K; Shah P; Shah MA; Mudassar S
Cell Oncol (Dordr); 2014 Aug; 37(4):245-52. PubMed ID: 25008999
[TBL] [Abstract][Full Text] [Related]
14. Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status.
Kakkar A; Kumar A; Jha P; Goyal N; Mallick S; Sharma MC; Suri A; Singh M; Kale SS; Julka PK; Sarkar C; Suri V
Neuropathology; 2014 Aug; 34(4):333-42. PubMed ID: 24521400
[TBL] [Abstract][Full Text] [Related]
15. Methylation and expression profiles of MGMT gene in thymic epithelial tumors.
Mokhtar M; Kondo K; Namura T; Ali AH; Fujita Y; Takai C; Takizawa H; Nakagawa Y; Toba H; Kajiura K; Yoshida M; Kawakami G; Sakiyama S; Tangoku A
Lung Cancer; 2014 Feb; 83(2):279-87. PubMed ID: 24388682
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of aberrant methylation of MGMT gene to MTHFR C677T genetic polymorphisms in esophageal squamous cell carcinoma].
Xue HC; Wang JM; Xu B; Guo GP; Hua ZL; Zhou Q; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2008 Dec; 27(12):1256-62. PubMed ID: 19079989
[TBL] [Abstract][Full Text] [Related]
17. O⁶-Methylguanine-DNA methyltransferase gene promoter methylation detection in glioma tumors by a novel fluorescence polarization assay.
Wu Z; Zhang J; Cheng H; Liang P; Guo Y; Yan Z; Zhao J
Diagn Mol Pathol; 2010 Dec; 19(4):232-5. PubMed ID: 21051997
[TBL] [Abstract][Full Text] [Related]
18. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.
Jin J; Xie L; Xie CH; Zhou YF
Genet Mol Res; 2014 May; 13(2):4140-5. PubMed ID: 24938706
[TBL] [Abstract][Full Text] [Related]
20. Detection of O6-methylguanine-DNA methyltransferase gene promoter region methylation pattern using pyrosequencing and the effect of methylation pattern on survival, recurrence, and chemotherapy sensitivity in patients with laryngeal cancer.
Onerci Celebi O; Tezel GG; Hosal AS; Cengiz M; Gullu IH; Hayran M
Pathol Res Pract; 2016 May; 212(5):456-62. PubMed ID: 27067808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
